JTC Employer Solutions Trustee’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-26,156
Closed -$26K 330
2024
Q2
$26K Hold
26,156
﹤0.01% 272
2024
Q1
$41K Buy
+26,156
New +$41K ﹤0.01% 262